Browsing Tag
Paragon Therapeutics
1 post
Can Apogee Therapeutics convert its $300m public offering into real clinical momentum before 2028?
Discover how Apogee Therapeutics (NASDAQ: APGE) is deploying a $300 million public offering to expand its biologics pipeline and investor runway.